Rivera, Santiago
Centre National de la Recherche Scientifique · Aix-Marseille Université · Institut de Neurophysiopathologie
8 papers on CoChatORCID 0000-0001-6649-2712
Most cited papers
- Verified
Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate
Jourquin, J., Tremblay, E., Décanis, N., Charton, G., Hanessian, S., Chollet, A., Le Diguardher, T., Khrestchatisky, M., & Rivera, S. (2003) · European Journal of Neuroscience
Protease and Inhibitor MechanismsNeuroscience and Neuropharmacology Research
Cited by 178
- Verified
Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease
Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 176
- Verified
Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer’s disease
Girard, S. D., Jacquet, M., Baranger, K., Migliorati, M., Escoffier, G., Bernard, A., Khrestchatisky, M., Féron, F., Rivera, S., Roman, F. S., et al. (2014) · Hippocampus
Alzheimer's disease research and treatmentsMemory and Neural Mechanisms
Cited by 119
- Verified
Evidence for early cognitive impairment related to frontal cortex in the 5xFAD mouse model of Alzheimer’s disease.
Girard, S. D., Baranger, K., Gauthier, C., Jacquet, M., Bernard, A., Escoffier, G., Marchetti, E., Khrestchatisky, M., Rivera, S., & Roman, F. S. (2013) · Journal of Alzheimer s Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 107
- Verified
Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges
Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry
Protease and Inhibitor MechanismsAlzheimer's disease research and treatments
Cited by 94
- Verified
Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP
García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience
Alzheimer's disease research and treatmentsProtease and Inhibitor Mechanisms
Cited by 88
- Verified
Amino acid metabolism in tumour-bearing mice
Rivera, S., Azcón-Bieto, J., López-Soriano, F. J., Miralpeix, M., & Argilés, J. M. (1988) · Biochemical Journal
Amino Acid Enzymes and MetabolismCancer, Hypoxia, and Metabolism
Cited by 76
- Verified
MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer’s disease
Pilat, D., Paumier, J.-M., García-González, L., Louis, L., Stephan, D., Manrique, C., Khrestchatisky, M., Di Pasquale, E., Baranger, K., & Rivera, S. (2022) · Journal of Neuroinflammation
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free